Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Regenxbio Inc.

NASDAQ: RGNX · Life Sciences · 4 alerts · CIK 1590877

Share price
$7.32Close, Nov 16
Market cap
$484M
Shares outstanding
66.12MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Regenxbio Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Court & Legal Update

Regenxbio Court & Legal Update

REGENXBIO and UPenn entered into a settlement agreement with Sarepta Therapeutics and Catalent to resolve all patent infringement litigation regarding U.S. Patent Nos. 10,526,617 and 11,680,274. Sarepta will pay REGENXBIO $39.0 million and receive a covenant not to sue for future claims relating to gene therapy products using an AAVrh74-based capsid, including ELEVIDYS.

Counterparty
Sarepta Therapeutics, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.